**ASP Isotopes Inc. Completes Construction and Begins Commissioning of Silicon-28 Enrichment Facility** WASHINGTON, D.C., November 26, 2024 (GLOBE NEWSWIRE) – ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”) announced today the compl

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ASP Isotopes’s 8K filing here.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Read More